Lumexa Imaging Inc. Common Stock
LMRI | NASDAQ
$11.41
-$0.32 (-2.73%)
At close: Oct 30, 2026, 4:00 PM ET
$11.41
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:23 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Revenue | 1.02B | 948.87M | 935.93M |
Cost of Revenue | 905.9M | 852.61M | 836.96M |
Gross Profit | 117.19M | 96.26M | 98.97M |
Operating Income | 26.73M | 55.24M | 22.45M |
Interest Income | n/a | n/a | n/a |
Pretax Income | -32.22M | -79.19M | -119.25M |
Net Income | -47.1M | -94.1M | -122.23M |
Selling & General & Admin | 90.45M | 70.36M | 55.17M |
Research & Development | n/a | n/a | n/a |
Other Expenses | n/a | -29.34M | 21.36M |
Operating Expenses | 90.45M | 41.02M | 76.52M |
Interest Expense | 118.54M | 136.03M | 141.69M |
Selling & Marketing Expenses | n/a | n/a | n/a |
Cost & Expenses | 996.35M | 893.63M | 913.48M |
Income Tax Expense | 14.89M | 14.91M | 2.98M |
Shares Outstanding (Basic) | 70.98M | 94.57M | 94.57M |
Shares Outstanding (Diluted) | 70.98M | 94.57M | 94.57M |
EPS (Basic) | -0.66 | -1 | -1.29 |
EPS (Diluted) | -0.66 | -1 | -1.29 |
EBITDA | 141.71M | 114M | 94.58M |
EBIT | 86.32M | 56.83M | 22.45M |
Depreciation & Amortization | 55.39M | 57.16M | 72.14M |
Add to Watchlist
Select watchlists to add or remove LMRI